"However, with three deals already signed, including one with Sanofi for Lovenox, the company’s revenue ramp could be substantial over the next 2-3 years."
But how do they know ?....Aren't you supposed to inform the market , in particular the shareholders first ?
Have I missed something ?
If the market was told that officially ....well my attitude would be a whole lot different !!
regards Q
UNS Price at posting:
60.0¢ Sentiment: None Disclosure: Held
